LONDON, April 21 (Reuters) – New heart drugs hailed as
breakthrough treatments by researchers are struggling to gain
traction among prescribing doctors, posing a headache for makers
such as Novartis,…
The post New heart drugs struggle to win sales as doctors hold back appeared first on NASDAQ.